Key Takeaways
- • Ares Capital Corp reported modest earnings declines in Q1 2026 while maintaining strong funding capacity, signaling resilience despite elevated private credit redemptions and AI-related technology sector concerns.
- • Software and services represent approximately 22% of Ares Capital's loan portfolio as of March 31, 2026, with fair value of $29.5 billion versus amortized cost of $29.6 billion, indicating minimal valuation pressure across the segment.
- • An independent external review of Ares Capital's software portfolio determined that approximately 85% of holdings carry low AI-related risk, with only a limited subset flagged as vulnerable to artificial intelligence disruption.
- • Select software investments recorded significant markdowns, including Cornerstone OnDemand and Sunshine Software Holdings ($261.9 million combined exposure, marked 26% below cost), while other positions in Global Medical Response and FEH Group appreciated in value.
- • Despite heightened market scrutiny on private credit valuations and technology sector stability, Ares Capital's Q1 results suggest the firm is not bracing for material fallout from liquidity strains or AI-related disruptions to its borrower base.
Summary
Software and services accounted for approximately 22% of Ares Capital's loan portfolio at quarter-end, representing a slight portfolio reduction from prior levels. The firm reported total asset fair value of $29.5 billion against an amortized cost of $29.6 billion, a narrow variance that signals limited valuation pressure across the portfolio. Notably, anticipated markdowns across higher-risk assets—particularly in software—largely did not materialize at the scale some market participants had forecast, though selective write-downs did occur on individual positions.
The most significant markdown involved combined debt and equity exposure to Cornerstone OnDemand and Sunshine Software Holdings, which stood at $261.9 million as of March 31, 2026—approximately 26% below the $353.8 million cost basis. The steepest discount applied to a $137.5 million second-lien loan marked at $103.1 million. Additional markdowns were recorded on positions in Symplr Software, DigiCert, and CoreLogic. Conversely, select exposures including Global Medical Response and FEH Group were marked higher than prior valuations, indicating mixed performance across the software sector rather than broad-based deterioration.
CEO Kort Schnabel highlighted findings from an independent external review of the firm's software portfolio conducted over several months. The assessment concluded that AI-related risks remain contained, with approximately 85% of software holdings classified as low risk and only a limited number flagged as more vulnerable to artificial intelligence disruption. This independent validation provided quantified support for Ares Capital's valuation stance during a period when some market participants questioned the stability and reliability of private credit asset pricing more broadly.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.